Processa Pharmaceuticals, Inc.·4

Nov 28, 4:13 PM ET

Yorke Justin W 4

4 · Processa Pharmaceuticals, Inc. · Filed Nov 28, 2023

Insider Transaction Report

Form 4
Period: 2023-11-21
Transactions
  • Other

    Common Stock

    2023-11-2155,267464,623 total(indirect: By LLC)
Holdings
  • Common Stock

    74,729
Footnotes (1)
  • [F1]Represents a transfer of shares to a fund that the Reporting Person does not manage. As a result, the reporting person is no longer deemed to be the beneficial owner of such shares.

Documents

1 file
  • 4
    form4.xmlPrimary